Skip to main content

Peer Review reports

From: GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer

Original Submission
30 Sep 2022 Submitted Original manuscript
27 Feb 2023 Reviewed Reviewer Report
27 Mar 2023 Reviewed Reviewer Report
18 Apr 2023 Author responded Author comments - Liang Wu
Resubmission - Version 2
18 Apr 2023 Submitted Manuscript version 2
20 Apr 2023 Reviewed Reviewer Report
21 Apr 2023 Reviewed Reviewer Report
4 May 2023 Author responded Author comments - Liang Wu
Resubmission - Version 3
4 May 2023 Submitted Manuscript version 3
11 May 2023 Author responded Author comments - Liang Wu
Resubmission - Version 4
11 May 2023 Submitted Manuscript version 4
23 May 2023 Author responded Author comments - Liang Wu
Resubmission - Version 5
23 May 2023 Submitted Manuscript version 5
8 Jun 2023 Author responded Author comments - Liang Wu
Resubmission - Version 6
8 Jun 2023 Submitted Manuscript version 6
27 Jun 2023 Author responded Author comments - Liang Wu
Resubmission - Version 7
27 Jun 2023 Submitted Manuscript version 7
6 Jul 2023 Author responded Author comments - Liang Wu
Resubmission - Version 8
6 Jul 2023 Submitted Manuscript version 8
11 Jul 2023 Author responded Author comments - Liang Wu
Resubmission - Version 9
11 Jul 2023 Submitted Manuscript version 9
Publishing
13 Jul 2023 Editorially accepted
28 Jul 2023 Article published 10.1186/s12905-023-02547-1

You can find further information about peer review here.

Back to article page